Grants
Karyopharm is committed to supporting and partnering with the healthcare community to help advance scientific breakthroughs and improve the lives of patients.
Medical Education Grants
We are committed to cancer research and treatment using novel first-in-class drugs directed against nuclear transport and related targets. Karyopharm may provide funding to eligible applicants requesting support for unbiased, evidence-based, independent medical education activities targeting unmet educational needs in the areas of interest to the company.
We support medical education grants in the following disease states: Multiple Myeloma (MM), Endometrial Cancer (EC), Myelofibrosis (MF), and Diffuse Large B-Cell Lymphoma (DLBCL).
Education grants are not provided to individuals or private group practices. In addition, provision of education grants is not conditioned in any way on the use, purchase, prescription or recommendation of any current or future Karyopharm product.
Submit Your Grant Request Here
Questions and/or requests for consideration of medical education grants should be submitted using the Contact Form.